Gene Expression Profiling for Diagnosing Carcinoma of Unknown Primary
Author Information
Author(s): Bridgewater J, van Laar R, Floore A, Van'T Veer L
Primary Institution: University College London Cancer Institute
Hypothesis
Can gene expression profiling improve the diagnosis of patients with carcinoma of unknown primary (CUP)?
Conclusion
Gene expression profiling can significantly improve the diagnosis of CUP and influence patient management strategies.
Supporting Evidence
- Gene expression profiling confirmed the clinicians' suspicion in 16 out of 21 cases.
- The improved diagnoses would have influenced management in 12 out of 21 cases.
- Patients with CUP often have a poor prognosis, with median survival between 3 and 6 months.
Takeaway
This study shows that using a special test called gene expression profiling can help doctors figure out where a cancer is coming from when they can't find the original tumor.
Methodology
The study analyzed paraffin tumor samples from 21 CUP patients using gene expression microarray analysis to classify tumor origins.
Limitations
The study was retrospective and may not represent all CUP patients, as it excluded certain subgroups.
Participant Demographics
Median age was 65 years, with a mix of male and female patients (10 males, 11 females).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website